Találati lista | Tudóstér

001-es BibID:	BIBFORM038814
Első szerző:	Batár István (szülész-nőgyógyász)
Cím:	State-of-the-art of intrauterine contraception / Batár I.
Dátum:	2006
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	The European Journal of Contraception and Reproductive Health Care. - 11 : 4 (2006), p. 262-269. -
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM035322
035-os BibID:	PMID:16854681
Első szerző:	Ganacharya, Sanjay
Cím:	Pre-malignant and malignant cervical pathologies among inert and copper-bearing intrauterine contraceptive device users : a 10-year follow-up study / Sanjay Ganacharya, Harjit P. Bhattoa, István Batár
Dátum:	2006
ISSN:	13625187
Megjegyzések:	Objectives: The aim of the study was to compare the incidence of pre-malignant and malignant cervical conditions during a period of 10 years of use of inert (Szontagh) and copper-bearing IUCDs. Methods: Candidates were parous women requesting intrauterine contraception regardless of the previous IUCD use and having no contraindications. Follow-ups were scheduled at 1, 6, and 12 months after insertion, and annually thereafter. Colposcopy and cytological evaluation were performed at insertion and at yearly follow-ups. For comparison of the two groups and the different follow-up periods (at the end of each ordinal year), net and gross cumulative lifetable rates were calculated. Statistical differences were measured by chi-squared test, and were regarded as significant at P ?ë♯n 0.05. Results: The total number of insertions was 3536 and 13,518 for inert and copper devices, respectively, and the maximum cumulative woman months of use (CWMU) at 10 years for the two groups were 163,567 and 492,836, respectively. There were no statistically significant differences in the life table rates of terminations for suspected cervical pre-malignant and malignant conditions between the groups at the end of each ordinal year. Conclusion: The copper-bearing intrauterine contraceptive devices are not associated with a significantly higher risk of cervical cancer compared to the inert IUCDs. ?? 2006 European Society of Contraception.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban Cervical carcinoma Copper-bearing Inert IUCD Non-medicated copper intrauterine device multiload copper intrauterine device adult article cancer incidence cancer risk carcinoma in situ chi square distribution colposcopy cytodiagnosis device removal dysplasia female follow up histopathology human human tissue intermethod comparison intrauterine contraceptive device invasive carcinoma life table major clinical study Papanicolaou test pathology precancer priority journal statistical analysis statistical significance uterine cervix cancer uterine cervix carcinoma Adult Chi-Square Distribution Female Follow-Up Studies Humans Hungary Incidence Intrauterine Devices Intrauterine Devices, Copper Precancerous Conditions Uterine Cervical Neoplasms egyetemen (Magyarországon) készült közlemény
Megjelenés:	European Journal of Contraception and Reproductive Health Care. - 11 : 2 (2006), p. 89-97. -
További szerzők:	Bhattoa Harjit Pal (1973-) (laboratóriumi szakorvos) Batár István (1942-) (szülész-nőgyógyász)
Internet cím:	elektronikus változat Intézményi repozitóriumban (DEA) tárolt változat DOI
Borító:
Saját polcon:

001-es BibID:	BIBFORM019653
Első szerző:	Póka Róbert (szülész-nőgyógyász, klinikai onkológus)
Cím:	Increased titer of anti-beta2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use / R. Póka, S. Vad, G. Lakos, Z. Bereczki, E. Kiss, S. Sipka
Dátum:	2004
ISSN:	0010-7824
Megjegyzések:	The risk of thromboembolism during oral contraceptive (OC) use is increased among factor V Leiden (FVL) carriers compared to women with wild-type genotype of the gene for coagulation factor V (FV). The carrier frequency in the general population is too high for FVL alone to be responsible for the reported association. Additional risk factors may be required to explain the increased risk of thromboembolism of carriers during OC use. We conducted a case-control study to compare the titer of anti-beta2-glycoprotein I immunoglobulin G (IgG) and the frequency of elevated titer of IgG type anti-beta2-glycoprotein I antibody between FVL carriers and individuals with FV wild-type genotype with and without pill use. An asymptomatic population of 313 unrelated nonpregnant women were screened for FVL and for the presence of anti-beta2-glycoprotein I IgG antibody. Sixty-six women were FVL carriers and 247 had normal genotype. One-hundred and thirty-five women used OC at the time of screening and 178 did not. Among FVL carriers, OC pill users had a higher mean anti-beta2-glycoprotein I IgG titer than nonusers (9.2 SGU/mL vs. 4.7 SGU/mL, p = 0.0485). Among women with FV wild-type genotype, there was no significant difference in anti-beta2-glycoprotein I IgG titers between users and nonusers of OCs (6.4 SGU/mL and 6.0 SGU/mL, respectively; p = 0.7010). The odds of an elevated anti-beta2-glycoprotein I IgG titer during OC use in FVL heterozygous women was 2.41 (95% confidence interval: 0.79-7.39) relative to users with-type genotype. FVL may contribute to the development of elevated titer of IgG type anti-beta2-glycoprotein I antibody during OC use. The elevated titer of IgG type anti-beta2-glycoprotein I antibody may select women among FVL carriers during OC use with an increased risk of thromboembolism.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban egyetemen (Magyarországon) készült közlemény
Megjelenés:	Contraception 69 : 1 (2004), p. 27-30. -
További szerzők:	Vad Szilvia (1976-) (nőgyógyász) Lakos Gabriella (1963-) (laboratóriumi szakorvos, transzfúziológus, immunológus) Bereczky Zsuzsanna (1974-) (orvosi laboratóriumi diagnosztika szakorvos) Kiss Emese (1960-) (belgyógyász, immunológus) Sipka Sándor (1945-) (laboratóriumi szakorvos)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: